CAS: 1010-26-0; 1,1-Cyclohexanediacetic Anhydride

该化合物是一个环形二角酮,具有螺旋状面状的牛皮质结构,具有独特的回活动性和稳定性,其僵硬的螺旋状框架加强了消毒控制,使其成为有机合成的宝贵中间体,特别是用于建造复杂的外环循环和功能化环系.该化合物的双碳基化合物组为核循环添加,凝聚和循环反应提供了多功能性.其稳定性在各种条件下允许广泛应用医药和农用化学研究.spiro结构也有助于形成符合性限制,有助于设计具有精确立体化学特性的生物活性分子.该化合物特别适合于需要受控环状打开或环状系统功能化的应用.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号4355-11-7 1,1-环己基二乙酸 | CAS号4355-15-1 3-Azaspiro[5.5]... | CAS号99189-60-3 1,1-环已基二乙酸单酰胺(CAM) | CAS号60142-96-3 加巴喷丁 | CAS号113009-25-9 2-[1-(2-oxo-2-p... | CAS号60142-94-1 1,1-环己基二乙酸单甲酯 | CAS号6051-08-7 3-oxaspiro[5.5]...

合成工艺路线路线简述

    2,4-二氧代-3-氮杂螺[5.5]十一烷-1,5-二甲腈置于盐酸,水,乙酸酐,溶剂黄146体系中,化学反应 88.0H,反应生成1,1-环己基二乙酸酐
    参考文献:Antiarthritic And Supressor Cell Inducing Activity Of Azaspiranes: Structure-Function Relationships Of A Novel Class Of Immunomodulatory Agents
    标题:Antiarthritic And Supressor Cell Inducing Activity Of Azaspiranes: Structure-Function Relationships Of A Novel Class Of Immunomodulatory Agents
    摘要:Spirogermanium (1; 8,8-Diethyl-N,N-Dimethyl-2-Aza-8-Germaspiro[4.5]Decane-2-Propanamine Dihydrochloride) Is A Potent Cytotoxic Agent In Vitro Which Has Demonstrated Limited Activity In Experimental Animal Tumor Models. Subsequently,It Has Been Reported That Spirogermanium Has Antiarthritic And Suppressor Cell-Inducing Activity. We Have Synthesized A Series Of Substituted 8-Hetero-2-Azaspiro[4.5]Decane And 9-Hetero-3-Azaspiro[5.5]Undecane Analogues Of Spirogermanium To Identify The Heteroatom Requirements For In Vivo Antiarthritic And Suppressor Cell-Inducing Activity. This Structure-Activity Relationship Study Has Identified That Appropriately Substituted Silicon And Carbon Analogues Of Spirogermanium Retain Both Antiarthritic And Immunosuppressive Activity,With The 8,8-Dipropyl (Carbon) Analogue Being Among The Most Active. Following The Identification Of N,N-Dimethyl-8,8-Dipropyl-2-Azaspiro[4.5]Decane-2-Propanamine++ + Dihydrochloride (9) As A More Active Analogue Than Spirogermanium,A Series Of 8,8-Dipropyl Analogues With Various Amine Substituents Were Synthesized. A Number Of These Analogues Had Activity Similar To That Of 9. A Correlation Between Activity In The Adjuvant Arthritic Rat And The Ability To Induce Suppressor Cells (R = 0.894,P Less Than 0.001) Suggests An Association Between The Two Pharmacologic Effects. While The Precise Biochemical Mechanism(S) For The Pharmacological Activity Is Unclear,These Data Suggest That Compounds Within This Series,E.G.,N,N-Dimethyl-8,8-Dipropyl-2-Azaspiro[4.5]Decane-2-Propanamine++ + Dihydrochloride,May Provide Effective Therapy In Diseases Of Autoimmune Origin And/or The Prevention Of Rejection In Tissue Transplantation.
    Doi:10.1021/jm00173A010

    海关参考信息

    专利信息


    专利号:US-2008103334-A1
    优先权日:2006-10-26
    标 题:Process For Synthesis Of Gabapentin
    发明人:KUMAR ASHOK; SOUDAGAR SATISH RAJANIKANT; NIJASURE AVINASH MANOHAR; PANDA NALINAKSHYA BALARAM; GAUTAM PRASHANT; THAKUR GAJENDRASINGH RAMSINGH
    权利人:IPCA LAB LTD
    摘要:A process for preparation of gabapentin comprising a step of obtaining 1,1-cyclohexane diacetic acid monoamide from 1,1-cyclohexane diacetic acid anhydride, wherein said reaction is characterized by the use of ammonia precursor or pre-generated ammonia-isopropanol solution. The invention further discloses preparation of gabapentin and isolation of gabapentin in polymorphic Form II with high yield and purity.

    专利号:US-7759517-B2
    优先权日:2004-06-24
    标 题:Process for the preparation of gabapentin
    发明人:VILLA MARCO; PAIOCCHI MAURIZIO; ARRIGHI KATIUSCIA; CORCELLA FRANCESCO; CANNATA VINCENZO; SORIATO GIORGIO; VERZINI MASSIMO
    权利人:ZACH SYSTEM SPA
    摘要:The present invention relates to a process for the preparation of gabapentin and, more in particular, to a method of synthesis of 1,1-cyclohexane acetic acid monoamide, an intermediate used in the preparation of gabapentin, comprising the basic hydrolysis reaction of α, -diaminocarbonyl-β,β-pentamethylene glutarimide.

    专利号:US-8143437-B2
    优先权日:2002-02-19
    标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
    发明人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X
    权利人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X; XENOPORT INC
    摘要:The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.

    专利号:US-2005239725-A1
    优先权日:2002-02-19
    标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof

    专利号:US-4810778-A
    优先权日:1986-01-16
    标 题 :Intermediates for preparing 1,6-dicarba-vasopressin compounds
    发明人:CALLAHAN JAMES F; HUFFMAN WILLIAM F; NEWLANDER KENNETH A; YIM NELSON C F
    权利人:SMITHKLINE BECKMAN CORP
    摘要:New compounds which have potent V2-vasopressin antagonistic activity are prepared by a 1,6-cyclization using peptide bond formation. The structures of the compounds are characterized by the Pas1,6 or Tas1,6 cyclized unit. Also a chiral synthesis of the optically pure Pas intermediates is described.

    专利号:US-4760052-A
    优先权日:1986-01-16
    标 题 :1,6-dicarba-vasopressin compounds
    发明人:CALLAHAN JAMES F; HUFFMAN WILLIAM F; NEWLANDER KENNETH A; YIM NELSON C F
    权利人:SMITHKLINE BECKMAN CORP
    摘要:New compounds which have potent V2-vasopressin antagonistic activity are prepared by a 1,6-cyclization using peptide bond formation. The structures of the compounds are characterized by a Pas1,6 or Tas1,6 cyclized unit. Also a chiral synthesis of the optically pure Pas intermediates is described.
    常州康运精细化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.comwin-china.com
    电话: 0519-86619955👤
    📞常州康运精细化工有限公司 ⚠️参考联系方式

    销售电话:0519-86619955
    邮箱:info@comwin-china.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    太仓运通生物化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.tcytchem.com
    电话: 0512-53640999👤
    📞太仓运通生物化工有限公司 ⚠️参考联系方式

    销售电话:0512-53640999
    邮箱:sales@tcytchem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Nagahisa Yamaoka, Et Al. Structure-Activity Relationships Of New N-Acylanthranilic Acid Derivatives As Plasminogen Activator Inhibitor-1 Inhibitors. Chem Pharm Bull (Tokyo). 2011;59(2):215-24.

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知